Due to the COVID-19 pandemic, the global Extracorporeal Lithotripters market size is estimated to be worth US$ 364 million in 2021 and is forecast to a readjusted size of US$ 514.8 million by 2028 with a CAGR of 5.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Extracorporeal Lithotripters market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Extracorporeal Lithotripters landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
With Lithotripsy Table accounting for % of the Extracorporeal Lithotripters global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Extracorporeal Lithotripters include Alpha Pharmaceuticals (Germany), CellSonic Medical (Arab), Direx (Germany), EDAP TMS (France), ELITE Medical (USA), ELMED Medical Systems (Turkey), EMD Medical Technologies (Turkey), GEMSS Medical Systems (Korea) and Inceler Medikal (Turkey), etc. In terms of revenue, the global 3 largest players have a % market share of Extracorporeal Lithotripters in 2021.
This report focuses on Extracorporeal Lithotripters volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Extracorporeal Lithotripters market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Extracorporeal Lithotripters Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
With Lithotripsy Table
With C-arm
With Endoscopy Column
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Alpha Pharmaceuticals (Germany)
CellSonic Medical (Arab)
Direx (Germany)
EDAP TMS (France)
ELITE Medical (USA)
ELMED Medical Systems (Turkey)
EMD Medical Technologies (Turkey)
GEMSS Medical Systems (Korea)
Inceler Medikal (Turkey)
Jena Med Tech (Germany)
Medispec (USA)
MS Westfalia (Germany)
MTS Medical (Germany)
NOVAmedtek (Arab)
Richard Wolf (Germany)
Shenzhen Huikang Medical Apparatus (China)
Shenzhen Hyde Medical Equipment (China)
Storz Medical (Switzerland)
US Healthcare Solutions (USA)